Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

115.57
+2.702.39%
Volume:2.32M
Turnover:267.36M
Market Cap:228.26B
PE:19.69
High:115.97
Open:114.77
Low:114.43
Close:112.87
Loading ...

Novartis shareholders approve dividend increase to CHF 3.50 per share

TIPRANKS
·
07 Mar

3 Top Cancer Biotechs to Keep An Eye On in 2025

Zacks
·
07 Mar

Barnes & Noble Education Names New Chief Accounting Officer, General Counsel

MT Newswires Live
·
07 Mar

Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss

Benzinga
·
07 Mar

Novartis AG (NVS): Among the Best Undervalued Stocks to Invest In Now

Insider Monkey
·
06 Mar

Novartis Earns Near-Best Overall Rating As Profit Growth Climbs

Blockhead
·
05 Mar

DA Davidson Downgrades Novartis to Neutral From Buy, Price Target is $120

MT Newswires Live
·
04 Mar

Novartis Earnings Surprised The Street; Still Going Strong Despite Market Correction

Blockhead
·
04 Mar

Novartis Gets CHMP Opinion for Label Expansion of Fabhalta

Zacks
·
03 Mar

Q4 2024 PTC Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Mar

Drug Stocks Are the New Safe Bet in a Shaky Market

Dow Jones
·
28 Feb

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

GlobeNewswire
·
28 Feb

Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)

GlobeNewswire
·
28 Feb

PTC Therapeutics Inc (PTCT) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ...

GuruFocus.com
·
28 Feb

Q4 2024 Schrodinger Inc Earnings Call

Thomson Reuters StreetEvents
·
27 Feb

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

GuruFocus.com
·
27 Feb